Skip to main content
NanoRepro AG logo

NanoRepro AG — Investor Relations & Filings

Ticker · NN6 ISIN · DE0006577109 LEI · 3912008FCA63AGIMEV74 F Manufacturing
Filings indexed 412 across all filing types
Latest filing 2026-04-22 Earnings Release
Country DE Germany
Listing F NN6

About NanoRepro AG

https://www.nanorepro.com/en/

NanoRepro AG is a company specializing in the development, manufacturing, and distribution of CE-marked rapid diagnostic tests (self-tests) and food supplements. The products are designed for both home and professional use. The company's portfolio covers various health areas, including family planning, preventive healthcare, disease detection, food intolerances, allergies, and infectious diseases. The primary goal is to provide accuracy in self-diagnostics for rapid disease detection and health monitoring.

Recent filings

Filing Released Lang Actions
NanoRepro AG: Beteiligungen als Wachstumsmotor im Geschaftsjahr 2025 Strategische Fokussierung schafft Grundlage fur profitables Wachstum
Earnings Release Classification · 87% confidence The document is a corporate news/financial press release issued via EQS News on April 22, 2026. It provides a high‐level summary of preliminary full‐year 2025 financial results (revenues, strategic highlights, outlook) rather than the complete annual report. This matches the definition of an Earnings Release (initial announcement of periodical financial results). FY 2025
2026-04-22 German
NanoRepro AG: Neues Vorstandsmitglied und Einleitung eines strategischen Reviewprozesses Die Transformation nimmt Fahrt auf
Board/Management Information Classification · 87% confidence The document is a corporate press release announcing the appointment of a new board member (Vorstandsmitglied) and the departure of a prior member, along with an organizational strategic review. It clearly falls under announcements of changes in the company's board or senior management, matching the Board/Management Information category.
2026-04-02 German
NanoRepro AG beschliet Barkapitalerhohung mit Bezugsrechtsausschluss aus genehmigtem Kapital im Umfang von bis zu 10% des Grundkapitals
Capital/Financing Update Classification · 100% confidence The document is an official ad-hoc announcement (insider information) regarding a capital increase (Barkapitalerhöhung) by NanoRepro AG. It details the issuance of new shares, the exclusion of subscription rights, and the intended use of proceeds. This falls under the category of capital structure changes and financing activities, which is classified as CAP.
2026-02-24 German
Jahresabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
Annual Report Classification · 100% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for Oehmichen Optik AG for the fiscal year 2024. It contains a balance sheet (Bilanz), profit and loss statement (Gewinn- und Verlustrechnung), and notes (Anhang). This constitutes a comprehensive annual financial report. In the context of the provided categories, this fits the definition of an Annual Report (10-K), as it provides the full financial performance and activity for the fiscal year. FY 2024
2026-02-19 German
NanoRepro AG: Veranderungen im Aufsichtsrat
Board/Management Information Classification · 100% confidence The document is a corporate news announcement from NanoRepro AG regarding changes in its supervisory board (Aufsichtsrat). It details the election of new members and the appointment of a new chairman following an extraordinary general meeting. This falls directly under the category of board or management changes.
2026-01-19 German
NanoRepro AG: Aufsichtsratsmitglied kundigt Amtsniederlegung an
Board/Management Information Classification · 100% confidence The document is a corporate news announcement regarding the resignation of a member of the supervisory board (Aufsichtsratsmitglied) of NanoRepro AG. This falls under the category of board or management changes.
2026-01-13 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.